Physician profile
David Le
NPI 1902566458
$1,373.45
in general payments reported to CMS, 2019-2025
16 companies · $545 in 2025
The $545 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $76.99 · 2024: $751 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,373.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $231.72 | 2023-2025 | |
| Abbott Laboratories | $184.14 | 2025 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $156.64 | 2024-2025 | Uzedy, Austedo Xr |
| Pfizer INC. | $124.70 | 2024-2025 | |
| Kyowa Kirin, INC. | $121.81 | 2024 | Crysvita |
| Astrazeneca Pharmaceuticals Lp | $116.06 | 2024 | Airsupra |
| Exeltis, USA INC. | $115.63 | 2024-2025 | Slynd |
| Organon LLC | $97.98 | 2024-2025 | Nexplanon |
| Glaxosmithkline, LLC. | $47.61 | 2025 | Arexvy, Shingrix |
| Hologic Sales and Service, LLC | $42.49 | 2025 | Aptima, Thinprep 2000 Processor, Third Wave |
| Lilly USA, LLC | $33.92 | 2025 | Mounjaro, Zepbound |
| Sanofi Pasteur INC. | $25.81 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.25 | 2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $16.98 | 2025 | Abilify Asimtufii |
| Dexcom, INC. | $16.70 | 2025 | Dexcom G6 Transmitter |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.01 | 2025 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.